#surface-antigens — Thursday, September 10, 2026 (1 items)
| 0 | ℹ |
Cancer-driver-agnostic targeting of amplified surface proteins identifies MPZL1 for selective CAR-T cell therapy.
(nature.com)
|
Nature Communications 2026-09-10 | #cancer #immunotherapy #car-t #surface-antigens #therapeutics |